Sec. 38a-492b. Coverage for off-label drug prescriptions. - Connecticut Statutes

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-492b

      Sec. 38a-492b. Coverage for off-label drug prescriptions. (a) Each individual health insurance policy delivered, issued for delivery or renewed in this state on or after October 1, 1994, which provides coverage for prescribed drugs approved by the federal Food and Drug Administration for treatment of certain types of cancer shall not exclude coverage of any such drug on the basis that such drug has been prescribed for the treatment of a type of cancer for which the drug has not been approved by the federal Food and Drug Administration, provided the drug is recognized for treatment of the specific type of cancer for which the drug has been prescribed in one of the following established reference compendia: (1) The U.S. Pharmacopoeia Drug Information Guide for the Health Care Professional (USP DI); (2) The American Medical Association's Drug Evaluations (AMA DE); or (3) The American Society of Hospital Pharmacists' American Hospital Formulary Service Drug Information (AHFS-DI).

      (b) Nothing in subsection (a) of this section shall be construed to require coverage for any experimental or investigational drugs or any drug which the federal Food and Drug Administration has determined to be contraindicated for treatment of the specific type of cancer for which the drug has been prescribed.

      (c) Nothing in this section shall be construed to create, impair, limit or modify authority to provide reimbursement for drugs used in the treatment of any other disease or condition.

      (P.A. 94-49, S. 2.)

      See Sec. 38a-518b for similar provisions re group policies.

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-492b

      Sec. 38a-492b. Coverage for off-label drug prescriptions. (a) Each individual health insurance policy delivered, issued for delivery or renewed in this state on or after October 1, 1994, which provides coverage for prescribed drugs approved by the federal Food and Drug Administration for treatment of certain types of cancer shall not exclude coverage of any such drug on the basis that such drug has been prescribed for the treatment of a type of cancer for which the drug has not been approved by the federal Food and Drug Administration, provided the drug is recognized for treatment of the specific type of cancer for which the drug has been prescribed in one of the following established reference compendia: (1) The U.S. Pharmacopoeia Drug Information Guide for the Health Care Professional (USP DI); (2) The American Medical Association's Drug Evaluations (AMA DE); or (3) The American Society of Hospital Pharmacists' American Hospital Formulary Service Drug Information (AHFS-DI).

      (b) Nothing in subsection (a) of this section shall be construed to require coverage for any experimental or investigational drugs or any drug which the federal Food and Drug Administration has determined to be contraindicated for treatment of the specific type of cancer for which the drug has been prescribed.

      (c) Nothing in this section shall be construed to create, impair, limit or modify authority to provide reimbursement for drugs used in the treatment of any other disease or condition.

      (P.A. 94-49, S. 2.)

      See Sec. 38a-518b for similar provisions re group policies.

State Codes and Statutes

Back To Homepage

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-492b

      Sec. 38a-492b. Coverage for off-label drug prescriptions. (a) Each individual health insurance policy delivered, issued for delivery or renewed in this state on or after October 1, 1994, which provides coverage for prescribed drugs approved by the federal Food and Drug Administration for treatment of certain types of cancer shall not exclude coverage of any such drug on the basis that such drug has been prescribed for the treatment of a type of cancer for which the drug has not been approved by the federal Food and Drug Administration, provided the drug is recognized for treatment of the specific type of cancer for which the drug has been prescribed in one of the following established reference compendia: (1) The U.S. Pharmacopoeia Drug Information Guide for the Health Care Professional (USP DI); (2) The American Medical Association's Drug Evaluations (AMA DE); or (3) The American Society of Hospital Pharmacists' American Hospital Formulary Service Drug Information (AHFS-DI).

      (b) Nothing in subsection (a) of this section shall be construed to require coverage for any experimental or investigational drugs or any drug which the federal Food and Drug Administration has determined to be contraindicated for treatment of the specific type of cancer for which the drug has been prescribed.

      (c) Nothing in this section shall be construed to create, impair, limit or modify authority to provide reimbursement for drugs used in the treatment of any other disease or condition.

      (P.A. 94-49, S. 2.)

      See Sec. 38a-518b for similar provisions re group policies.